Automation Solutions for SARS-CoV-2 Variant Identification and Surveillance
MGI Mobile Platforms Total Solution for Automated & Integrated Nucleic Acid Testing
More and more people worry about the limited medical resources problem when the number of confirmed COVID-19 cases keep increasing. To better control and eventually end the global pandemic soon, increasing nucleic acid testing capability quickly is of great importance. For this reason, MGI provides new mobile platform solutions! Project Manager would bring you a closer look of different throughput solutions and share with you some real cases for the fight against the pandemic.
Benny Zhida Chen & Xiongfei LiProject Manager
If you have any questions, you can send an email to: